ABBV Total Debt
Short-term plus long-term borrowings at each quarter end, before any offset for cash.
Total Debt
Latest: $70.82B (2026Q2)
| Period | Value |
|---|---|
| 2020Q3 | $87.06B |
| 2020Q4 | $86.06B |
| 2021Q1 | $85.53B |
| 2021Q2 | $82.14B |
| 2021Q3 | $80.72B |
| 2021Q4 | $76.68B |
| 2022Q1 | $73.47B |
| 2022Q2 | $72.93B |
| 2022Q3 | $69.61B |
| 2022Q4 | $63.27B |
| 2023Q1 | $62.09B |
| 2023Q2 | $61.02B |
| 2023Q3 | $60.75B |
| 2023Q4 | $59.38B |
| 2024Q1 | $74.00B |
| 2024Q2 | $70.63B |
| 2024Q3 | $71.08B |
| 2024Q4 | $67.14B |
| 2025Q1 | $69.89B |
| 2025Q2 | $70.48B |
| 2025Q3 | $68.74B |
| 2025Q4 | $67.50B |
| 2026Q1 | $72.86B |
| 2026Q2 | $70.82B |
Other ABBV Charts
More quarter-by-quarter fundamentals for AbbVie Inc.
1 / 10
Revenue
EPS
Free Cash Flow
Gross Margin
FCF Margin
P/E Ratio
Cumulative FCF
Shares Outstanding
Total Assets
Rule of 40
Healthcare Comparison
1 / 3
Latest Total Debt: $70.82B (2026Q2); +0.5% YoY; +12.4% CAGR since 2013Q1 (13.25y).
Across the 54 quarters from 2013Q1 to 2026Q2, Total Debt ranged from $14.41B in 2014Q1 to $87.43B in 2020Q2.
Chart and table show the latest 24 of 54 quarters.